SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-260762
Filing Date
2019-10-02
Accepted
2019-10-02 16:15:36
Documents
1
Period of Report
2019-09-26
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d814772d8k.htm 8-K 16488
  Complete submission text file 0001193125-19-260762.txt   17745
Mailing Address 401 TERRY AVENUE NORTH SEATTLE WA 98109
Business Address 401 TERRY AVENUE NORTH SEATTLE WA 98109 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 191132403
SIC: 2834 Pharmaceutical Preparations